Projects

AIP IN AUTOIMMUNITY

project name: AIP (Aire-Interacting Protein) regulates autoantigen expression

initiating country: The European Union

Framework Programme: FP6       programme area: MC – Marie Curie Actions       contract type: MCOIF – Marie Curie Outgoing International Fellowship

contract/proposal/call number: 40998

status: active

start date: February 2007       duration: 36 months       projected finish date: February 2010

Keywords

keywords: tolerance; thymus; AIRE

Project Budget

total budget: € 204,966

Participants

Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level.

nameorganisationstate or country
Dr Hamish ScottWEHI VIC, Australia
Inserm France

Further information

summary:

APECED patients suffer from tissue-specific destructive autoimmunity, affecting principally endocrine organs. They indicate a profound defect in immune maturation, especially in the mechanisms leading to tolerance against self-antigens, which occur during negative selection in the thymus. AIRE, the mutated gene in APECED and necessary for maintenance of T-cell tolerance, is responsible for intrathymic expression of peripheral autoantigens. Indeed, AIRE has an activity of transcriptional regulator. However the exact mechanism how AIRE influences the transcription of autoantigens remains elusive. The knowledge about AIRE functional targets and partners will have a significant input to the understanding of AIRE in these processes and immune tolerance in general. Recently Hamish’s group has discovered a new protein involved in epigenetic processes, which they are calling AIP (AIRE interacting protein). Only few things are known on this new and exiting molecule. Its expression and sub-cellular localization mirrors A IRE in the thymus in vivo and it also interact with AIRE in vitro. We purpose to analyse the role of AIP by multidisciplinary approach (genetic and immunology). Using uniqueness resources such as transgenics and KO technologies, we will study the general autoimmune phenomena in AIP KO mice. Then we will investigate the role of AIP in control of thymic selection and also the role of AIP in control of peripheral tolerance by cross presentation of self-antigens.

Sources: European Commission